12162017Headline:

Orlando, Florida

HomeFloridaOrlando

Email Sandy Grinnell, Staff Contributor Sandy Grinnell, Staff Contributor on LinkedIn Sandy Grinnell, Staff Contributor on Twitter Sandy Grinnell, Staff Contributor on Facebook
Sandy Grinnell, Staff Contributor
Sandy Grinnell, Staff Contributor
Contributor •

WalMart Recalls Mis-Labeled Insulin Syringes

Comments Off

According to an FDA Alert, Tyco Healthcare Group LP(Covidien) is recalling over 47,000 boxes of individual use, disposable insulin syringes due to possible mislabelling. The syringes were sold exclusively at WalMart and Sams Club stores under the name of ReliOn from August 1, 2008 through October 8, 2008.

The mislabelling involved a mixup of U-40 and U-100 syringes before they were individually wrapped and then boxed in 100-pack boxes. The possible mixup means a patient could receive two and a half times their normal dosage of insulin, possibly resulting in hypoglycemia, other health problems and even death.

The recall is for following product -

Lot Number 813900
— ReliOn 1cc, 31-gauge, 100 units for use with U-100 insulin

FDA officials are asking patients, physicians and other healtcare professionals to take a good look at their current supply of syringes to make certain they are not from Lot Number 813900. If you have any of these syringes, you should return them to WalMart or Sams Club for a free replacement. If you have any questions or concerns about your syringes, you may contact Covidien at 866-780-5436 or www.relion.com/recall for more information.